Jim Palma/targetcancer.org
Nov 18, 2024, 09:46
Jim Palma: The 2nd Rare Cancer Research Symposium at the Fred Hutch Cancer Center
Jim Palma, CEO at Target Cancer Foundation, shared a post on LinkedIn:
“Our Think Tank on Advancing Precision Medicine in Rare Cancers is a few days away, but this week I was fortunate to take a quick trip to Seattle to participate in the 2nd Rare Cancer Research Symposium at the Fred Hutch Cancer Center.
Many thanks to Taran G. for such a kind invitation to speak at this meeting, and to John Hopper for making this initial introduction.
Under Taran’s leadership the TRACER initiative at Fred Hutch is making incredibly rapid progress in driving rare cancer research, and I am excited for the collaborative opportunities that lie ahead.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 18, 2024, 20:54
Nov 18, 2024, 18:36
Nov 18, 2024, 18:32
Nov 18, 2024, 18:06
Nov 18, 2024, 18:00
Nov 18, 2024, 17:40